Clinical Trials Logo

714leukemia clinical trials

View clinical trials related to 714leukemia.

Filter by:
  • None
  • Page 1

NCT ID: NCT00671112 Terminated - Lymphoma Clinical Trials

Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma

Start date: June 2008
Phase: Phase 1
Study type: Interventional

RATIONALE: Everolimus and bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is studying the side effects and best dose of everolimus when given together with bortezomib in treating patients with relapsed or refractory lymphoma.